Zymergen Inc.

Zymergen Inc. (ZY) priced its initial public offering on Apr 23, 2021 at $31.00 per share, within its $28.00–$31.00 range, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $3.04B. J.P. Morgan was lead-left underwriter, joined by Goldman Sachs, BofA Securities and TD Cowen and others. Freshfields advised the company and Wilson Sonsini advised the underwriters.

Zymergen Inc. designs, develops and commercializes bio-based products by engineering microbes to make novel biomolecules, a process it calls biofacturing. Its first products are films for electronics companies, intended for devices such as rollable tablets and for UV protection.

Status

IPO

Ticker

ZY

Exchange

Nasdaq Global Select

Priced

Apr 23, 2021

IPO price

$31.00

Price range

$28.00–$31.00

Market cap at IPO price

$3.04B

First filed

Mar 23, 2021

Underwriters

J.P. Morgan, Goldman Sachs, BofA Securities, TD Cowen, UBS and Lazard

Company counsel

Freshfields

Underwriters' counsel

Wilson Sonsini

Sector

Biotech & pharma

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.